Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Autologous platelet-rich plasma (PRP) for treating androgenetic alopecia: a novel treatment protocol standardized on 2 cases (CROSBI ID 320150)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Maletić, Ana ; Dumić-Čule, Ivo ; Brlek, Petar ; Žic, Rado ; Primorac, Dragan Autologous platelet-rich plasma (PRP) for treating androgenetic alopecia: a novel treatment protocol standardized on 2 cases // Journal of clinical medicine, 11 (2022), 24; 7327, 7. doi: 10.3390/jcm11247327

Podaci o odgovornosti

Maletić, Ana ; Dumić-Čule, Ivo ; Brlek, Petar ; Žic, Rado ; Primorac, Dragan

engleski

Autologous platelet-rich plasma (PRP) for treating androgenetic alopecia: a novel treatment protocol standardized on 2 cases

Platelet-rich plasma (PRP) treatment has emerged in recent years as a valuable, effective, and affordable treatment for androgenetic alopecia. Androgenetic alopecia is the most common type of alopecia, affecting both men and women, and is characterized by diminished hair follicles mainly pronounced in the frontal region and vertex. A considerable variety of PRP treatment regimens have been described so far, but there is no consensus on the standardization of PRP preparation or administration protocol. Our study was conducted on two patients to test the efficacy of a new PRP application protocol of only two treatments by using a combination of a PRP collecting device and a conventional kit. Efficacy of treatment was assessed after a 6-month follow- up by artificial intelligence (AI)-driven software on microscopic images of treated regions. An average number of hairs, cumulative hair thickness, and the number of follicular units increased in the vertex region of both patients by 30/59%, 35/53%, and 14/48%, respectively. The novel treatment regimen showed significant effectiveness in only six months.

androgenetic alopecia ; platelet-rich plasma ; hair loss ; hair follicle

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

11 (24)

2022.

7327

7

objavljeno

2077-0383

10.3390/jcm11247327

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost